Farms.com Home   News

SOYBEAN GROWERS CONCERNED ABOUT EPA CHLORPYRIFOS RULEMAKING

Chlorpyrifos is back in the farmer’s toolbox for eleven crops, but soybean growers worry the EPA will take it away again.  Grower Tanner Johnson with the Wisconsin Soybean Association says, “Perhaps they would try to use some of the blanket rules that they’ve done in the past, which could negetively impact soybeans.”

Johnson says the Wisconsin Soybean Association is among the groups trying to ensure chlorpyrifos remains consistently available. “If you give them an inch, they may take a mile. That doesn’t just go for EPA. We’ve fought really hard to keep some of these tools in our toolbox, and to lose them can cause severe economic impact overnight, almost, in some instances.”

Johnson says another concern is the possible availability of chlorpyrifos since some major manufacturers have announced they won’t make it anymore. “There’s definitely concern among the farmers in the country that the demand may outweigh the overall supply.”

Johnson says his supplier is advising farmers to purchase chlorpyrifos early to avoid possible shortages.

The 8th U.S. Court of Appeals in St. Louis struck down EPA’s ban on chlorpyrifos, but EPA says it plans to issue new restrictions that would only allow use of the insecticide on alfalfa, apple, asparagus, tart cherries, citrus, cotton, peaches, soybeans, strawberries, sugar beets and wheat.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.